Read + Share
Verdina A, Di Segni M, Amoreo CA, Sperduti I, et al. HIPK2 is a potential predictive marker of a favorable response for adjuvant
chemotherapy in stage II colorectal cancer. Oncol Rep 2021;45:899-910.
PMID: 33650652
|
 |
|
Verdina A, Di Segni M, Amoreo CA, Sperduti I, et al. HIPK2 is a potential predictive marker of a favorable response for adjuvant
chemotherapy in stage II colorectal cancer. Oncol Rep 2021;45:899-910.
PMID: 33650652
|
|
|
|